| In vitro antiplasmodial activity of extracts and fractions from seven medicinal plants used in the Democratic Republic of Congo L Tona, RK Cimanga, K Mesia, CT Musuamba, T De Bruyne, S Apers, ... Journal of ethnopharmacology 93 (1), 27-32, 2004 | 461 | 2004 |
| Pharmacokinetics and dosage adjustment in patients with renal dysfunction RK Verbeeck, FT Musuamba European journal of clinical pharmacology 65, 757-773, 2009 | 374 | 2009 |
| In silico clinical trials: concepts and early adoptions F Pappalardo, G Russo, FM Tshinanu, M Viceconti Briefings in bioinformatics 20 (5), 1699-1708, 2019 | 256 | 2019 |
| In silico trials: Verification, validation and uncertainty quantification of predictive models used in the regulatory evaluation of biomedical products M Viceconti, F Pappalardo, B Rodriguez, M Horner, J Bischoff, ... Methods 185, 120-127, 2021 | 244 | 2021 |
| Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility FT Musuamba, I Skottheim Rusten, R Lesage, G Russo, R Bursi, L Emili, ... CPT: Pharmacometrics & Systems Pharmacology 10 (8), 804-825, 2021 | 97 | 2021 |
| General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy Z Li, GR Mirams, T Yoshinaga, BJ Ridder, X Han, JE Chen, ... Clinical Pharmacology & Therapeutics 107 (1), 102-111, 2020 | 87 | 2020 |
| Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study F Frippiat, FT Musuamba, L Seidel, A Albert, R Denooz, C Charlier, ... Journal of Antimicrobial Chemotherapy 70 (1), 207-216, 2015 | 86 | 2015 |
| Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients IK Delattre, FT Musuamba, J Nyberg, FS Taccone, PF Laterre, ... Therapeutic drug monitoring 32 (6), 749-756, 2010 | 75 | 2010 |
| Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in peripheral blood mononuclear cells A Capron, F Musuamba, D Latinne, M Mourad, J Lerut, V Haufroid, ... Therapeutic drug monitoring 31 (2), 178-186, 2009 | 75 | 2009 |
| Advanced methods for dose and regimen finding during drug development: summary of the EMA/EFPIA workshop on dose finding (London 4–5 December 2014) FT Musuamba, E Manolis, N Holford, SYA Cheung, LE Friberg, ... CPT: pharmacometrics & systems pharmacology 6 (7), 418-429, 2017 | 74 | 2017 |
| Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus FT Musuamba, A Rousseau, JL Bosmans, JJ Senessael, J Cumps, ... Clinical pharmacokinetics 48, 745-758, 2009 | 70 | 2009 |
| In vitro antiplasmodial activity of callus culture extracts and fractions from fresh apical stems of Phyllanthus niruri L. (Euphorbiaceae): part 2. VAJ Cimanga RK, Tona L, Luyindula N, Mesia K, Lusakibanza M, Musuamba CT ... J Ethnopharmacol., 399-404, 2004 | 67 | 2004 |
| A simultaneous d‐optimal designed study for population pharmacokinetic analyses of mycophenolic acid and tacrolimus early after renal transplantation FT Musuamba, M Mourad, V Haufroid, M Demeyer, A Capron, IK Delattre, ... The Journal of Clinical Pharmacology 52 (12), 1833-1843, 2012 | 58 | 2012 |
| Prediction of paraquat exposure and toxicity in clinically ill poisoned patients: a model based approach K Wunnapuk, F Mohammed, I Gawarammana, X Liu, RK Verbeeck, ... British Journal of Clinical Pharmacology 78 (4), 855-866, 2014 | 51 | 2014 |
| The revised EMA guideline for the investigation of bioequivalence for immediate release oral formulations with systemic action RK Verbeeck, FT Musuamba Journal of Pharmacy & Pharmaceutical Sciences 15 (3), 376-388, 2012 | 51 | 2012 |
| Time of drug administration, CYP3A5 and ABCB1 genotypes, and analytical method influence tacrolimus pharmacokinetics: a population pharmacokinetic study FT Musuamba, M Mourad, V Haufroid, IK Delattre, RK Verbeeck, ... Therapeutic drug monitoring 31 (6), 734-742, 2009 | 49 | 2009 |
| Is plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) determination in donors and recipients predictive of renal function after kidney transplantation? A Buemi, F Musuamba, S Frederic, A Douhet, M De Meyer, L De Pauw, ... Clinical biochemistry 47 (15), 68-72, 2014 | 48 | 2014 |
| Antimalarial efficacy of a quantified extract of Nauclea pobeguinii stem bark in human adult volunteers with diagnosed uncomplicated falciparum malaria. Part 2: a clinical … K Mesia, L Tona, MM Mampunza, N Ntamabyaliro, T Muanda, T Muyembe, ... Planta medica 78 (09), 853-860, 2012 | 46 | 2012 |
| Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin IK Delattre, FT Musuamba, P Jacqmin, FS Taccone, PF Laterre, ... Clinical biochemistry 45 (10-11), 780-786, 2012 | 45 | 2012 |
| Influence of Donor–Recipient CYP3A4/5 Genotypes, Age and Fluconazole on Tacrolimus Pharmacokinetics in Pediatric Liver Transplantation: A Population … V Guy-Viterbo, H Baudet, L Elens, V Haufroid, F Lacaille, M Girard, ... Pharmacogenomics 15 (9), 1207-1221, 2014 | 42 | 2014 |
